SEC Form D private-offering filing

Sernova Biotherapeutics Inc.

A new SEC Form D private-offering notice from Mississauga, ON, Canada, a $843,153 filer-stated offering target in Biotech. The source filing is one click away.

Sernova Biotherapeutics Inc. site↗ Verified via SEC Form D

Clinical stage regenerative medicine company developing the Cell Pouch, a bio hybrid implantable organ system, currently in trials for type 1 diabetes; trades on the TSX as SVA.

Filed 2026-02-05Filed to raise $843,153First money in 2025-10-31Raised so far $344,514HQ (as filed) Mississauga, ON, CanadaSector Biotech Stage (inferred) Pre-seedCall status Non-US principal office
Source linked the Form D on EDGAR↗Website verified sernova.com↗Named in the filing 9 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.